Estimate the prevalence of daily caffeine consumption, caffeine use disorder, caffeine withdrawal and perceived harm in Iran: a cross-sectional study
Abdoli F, Davoudi M, Momeni F, Djafari F, Dolatshahi B, Hosseinzadeh S, Aliyaki H, Khalili Z
Scientific reports · 16 citas
Cómo se estudió
- Diseño
- Estudio transversal (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación independiente
- Universidad u hospital
- University of Social Welfare and Rehabilitation Sciences
Según 1 financiador declarado y la declaración de financiación del texto completo.
Publicación
- Publicado
- 2024-04-01 · Sci Rep · vol. 14 · número 1 · pág. 7644
- Editorial
- Nature Portfolio
- Citado
- 21 citas · más que el 97% de estudios similares · 6.3× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 40 trabajos
- Acceso
- Acceso abierto (revista) · CC-BY
- Áreas de investigación
- Coffee research and impacts · Eating Disorders and Behaviors
- Palabras clave
- Caffeine, Medicine, Cross-sectional study, Psychiatry
- MeSH
- humans, substance withdrawal syndrome, caffeine, psychotropic drugs, prevalence, cross-sectional studies, aged, iran, female, male
8 autores
- Fatemeh Abdoli🇮🇷University of Social Welfare and Rehabilitation Sciences
- Mohammadreza Davoudi🇮🇷University of Social Welfare and Rehabilitation Sciences
- Fereshte Momeni🇮🇷University of Social Welfare and Rehabilitation Sciences
- Farhang Djafari🇮🇷Tehran University of Medical Sciences
- Behrooz Dolatshahi🇮🇷University of Social Welfare and Rehabilitation Sciences
- Samaneh Hosseinzadeh🇮🇷University of Social Welfare and Rehabilitation Sciences
- Hajar Aliyaki🇮🇷University of Social Welfare and Rehabilitation Sciences
- Zahra Khalili🇮🇷University of Social Welfare and Rehabilitation Sciences
Resumen
El texto original del estudio, en el idioma en que se publicó.
One of the informal diagnoses in DSM-5 is Caffeine Use Disorder (CUD). CUD and high levels of caffeine consumption could impact mental health conditions. This study aimed to estimate the prevalence of CUD, caffeine consumption, caffeine-related harms, and related psychiatric symptoms in Iran. A cross-sectional survey with a convenience sample of 1228 adults were conducted in Iran. Caffeine consumption was assessed across 20 products in Iran. Caffeine Use Disorder Questionnaire (CUDQ), Caffeine Withdrawal Symptoms Questionnaire (CWSQ), 14-item Caffeine-related Harm Screening (CHS), and Symptom Checklist-25 (SCL-25) were used in the present study. We used SPSS (desktop version 26.0) to analyze the data using descriptive statistics, chi-square, and the least significant difference (LSD) post hoc test. The daily average caffeine consumption was 146.67 mg. The prevalence of CUD and caffeine withdrawal (C.W.) were estimated at 19.5% and 46.62%, respectively. Also, 12.9% of responders received CUD and C.W.s simultaneously. The prevalence of CUD was higher in men than females (25.08% vs. 13.93%). 95% of participants (n = 1166) reported using at least one caffeine product yesterday. Moreover, the most reported caffeine-related harms were the desire for sugar (42.9%), insomnia (39.3%), and caffeine dependence (38.3%). Age significantly correlates with CUD (- 0.07) and daily caffeine intake (0.08). Moreover, all SCL-90 subscales had a significant correlation with daily caffeine intake. Finally, responders at younger ages reported higher levels of CUD and caffeine consumption than older adults(P < 0.05). High rates of C.W. and CUD in the Iranian population suggest that it is necessary to develop evidence-based treatments.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.